Evidence map›Paper›PMID 29623501›Full record

ArticleInternational urology and nephrology2018

Silymarin and celecoxib ameliorate experimental varicocele-induced pathogenesis: evidences for oxidative stress and inflammation inhibition.

Sara Mazhari, Mazdak Razi, Rajabali Sadrkhanlou

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Silymarin and Inflammation: Food for Thoughts.Antioxidants (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  15. Review
  16. Protective Effect of Aqueous Extract from the Leaves ofAntioxidants (Basel, Switzerland) · 2018
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sara MazhariDivision of Histology and Embryology, Department of Basic Science, Faculty of Veterinary Medicine, Urmia University, P.O. Box: 1177, Urmia, Iran.
Mazdak RaziDivision of Histology and Embryology, Department of Basic Science, Faculty of Veterinary Medicine, Urmia University, P.O. Box: 1177, Urmia, Iran. mazdak.razi@gmail.com.ORCID http://orcid.org/0000-0002-4309-4831
Rajabali SadrkhanlouDivision of Histology and Embryology, Department of Basic Science, Faculty of Veterinary Medicine, Urmia University, P.O. Box: 1177, Urmia, Iran.
Urmia University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe present study was done to investigate the ameliorative effect of silymarin (SMN) and celecoxib (CEL) on varicocele (VCL)-induced detrimental impact in testicular tissue.

methodsMature Wistar rats were divided into control and test groups. Following VCL induction, the animals in test group were subdivided into non-treated VCL-induced, SMN-treated (50 mg/kg, orally), CEL-treated (10 mg/kg) and SMN + CEL-treated groups. Following 60 days, testicular total antioxidant capacity (TAC), malondialdehyde (MDA), nitric oxide (NO), superoxide dismutase (SOD), glutathione peroxidase (GSH-px), total thiol molecules (TTM), mRNA and protein levels of COX2 and mRNA level of iNos were analyzed. Moreover, the germinal cells apoptosis and mRNA damage were examined.

resultsObservations revealed that co-administration of SMN and CEL significantly (P < 0.05) up-regulated TAC, SOD, GSH-px and TTM levels and resulted in a remarkable (P < 0.05) reduction in iNos and COX2 expression, NO and MDA contents. The animals in SMN + CEL-treated group exhibited significantly (P < 0.05) lower number of apoptotic cells and cells with mRNA damage per one mm

conclusionThe SMN by up-regulating testicular TAC, SOD, GSH-px and TTM levels and the CEL by inhibiting COX2 and iNos expression as well as NO content could fairly ameliorate the VCL-decreased spermatogenesis.

Indexed as

AnimalsAntioxidantsApoptosisCelecoxibCyclooxygenase 2Cyclooxygenase 2 InhibitorsDrug Therapy, CombinationGlutathione PeroxidaseInflammationMaleMalondialdehydeNitric OxideNitric Oxide Synthase Type IIOxidative StressRatsRats, WistarAntioxidantsCelecoxibCyclooxygenase 2Cyclooxygenase 2 InhibitorsGlutathione PeroxidaseMalondialdehydeNitric OxideNitric Oxide Synthase Type IINos2 protein, ratRNA, MessengerSilymarinSulfhydryl CompoundsSuperoxide DismutaseCOX2iNosOxidative stressTestisVaricocele

Identifiers

PMID29623501
OpenAlexW2795807563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.